Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) announced a quarterly cash dividend of $0.5107 per share, declared from the company's capital surplus.
The dividend is payable on January 15, 2026 to shareholders of record at the close of business on January 2, 2026.
Cardinal Health (NYSE: CAH) ha annunciato un dividendo trimestrale in contanti di $0.5107 per azione, dichiarato dall'eccedenza di capitale dell'azienda.
Il dividendo è pagabile il 15 gennaio 2026 agli azionisti registrati al 2 gennaio 2026 al termine delle attività.
Cardinal Health (NYSE: CAH) anunció un dividendo trimestral en efectivo de $0.5107 por acción, declarado a partir del superávit de capital de la empresa.
El dividendo se pagará el 15 de enero de 2026 a los accionistas registrados al cierre de operaciones del 2 de enero de 2026.
Cardinal Health (NYSE: CAH) 는 회사의 자본 잉여금에서 결정된 주당 $0.5107 달러의 분기 현금 배당금을 발표했습니다.
배당금은 2026년 1월 15일에 지급되며 2026년 1월 2일 영업 종료 시점에 등재된 주주들에게 지급됩니다.
Cardinal Health (NYSE: CAH) a annoncé un dividende trimestriel en espèces de $0,5107 par action, déclaré à partir du superflu de capital de l'entreprise.
Le dividende sera payable le 15 janvier 2026 aux actionnaires enregistrés à la clôture des opérations le 2 janvier 2026.
Cardinal Health (NYSE: CAH) hat eine vierteljährliche Bardividende von 0,5107 USD pro Aktie angekündigt, aus dem Kapitalüberschuss des Unternehmens.
Die Dividende wird am 15. Januar 2026 an die am Geschäftsschluss des 2. Januar 2026 eingetragenen Aktionäre zahlbar sein.
Cardinal Health (NYSE: CAH) أعلنت عن توزيعات نقدية ربع سنوية قدرها $0.5107 للسهم، متمركزة من فائض رأس المال للشركة.
سيتم الدفع في 15 يناير 2026 للمساهمين المسجلين بنهاية العمل في 2 يناير 2026.
- $0.5107 dividend per share declared
- Dividend payable Jan 15, 2026
- Record date set at Jan 2, 2026
- Declared from capital surplus
- Payment will reduce the companys capital surplus
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.
Contacts
Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and 614.757.8231
Investors: Matt Sims, matt.sims@cardinalhealth.com and 614.553.3661
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-board-of-directors-approves-quarterly-dividend-302604693.html
SOURCE Cardinal Health